Generation of antibodies to monitor Notch O-fucosylation in vivo

Information

  • Research Project
  • 9200115
  • ApplicationId
    9200115
  • Core Project Number
    R41GM119879
  • Full Project Number
    1R41GM119879-01A1
  • Serial Number
    119879
  • FOA Number
    PA-15-270
  • Sub Project Id
  • Project Start Date
    9/26/2016 - 8 years ago
  • Project End Date
    9/25/2017 - 7 years ago
  • Program Officer Name
    MARINO, PAMELA
  • Budget Start Date
    9/26/2016 - 8 years ago
  • Budget End Date
    9/25/2017 - 7 years ago
  • Fiscal Year
    2016
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    9/26/2016 - 8 years ago
Organizations

Generation of antibodies to monitor Notch O-fucosylation in vivo

Project Summary Notch1 is a cell surface protein that has diverse roles in human biology at all stages of life. Notch1 is modified by a number of sugar structures, including a number that are termed O-fucose. Alteration of the pattern of O- fucose structures found on Notch1 has significant effects on Notch1 function, which in turn has been linked to both developmental and adult pathologies, including cancer. To date the study of O-fucose structures on Notch1 has been severely hindered by a lack of research reagents that can specifically detect and monitor this structure. Currently, mass spectrometry is the method of choice for the analysis of O-fucose glycans on Notch1. Although an extremely powerful technique, it requires specialized instrumentation and expertise not available in most laboratories. Development of sensitive and specific antibodies for O-fucose glycans on Notch1 will provide many investigators with the tools to analyze O-fucose glycans in vivo, including clinical specimens. We will utilize a newly-developed methodology that enables reliable production of antibodies that can recognize distinct protein epitopes in the context of specific glycan modifications to produce antibodies to O- fucose on Notch1. If successful these O-fucose-Notch1-specific antibodies will facilitate research on Notch1 in many laboratories and possibly could lead to new diagnostic and therapeutic tools.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R41
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    242306
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:242306\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    GLYCOSCIENTIFIC, LLC
  • Organization Department
  • Organization DUNS
    829734347
  • Organization City
    ATHENS
  • Organization State
    GA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    306021514
  • Organization District
    UNITED STATES